Mendelian randomization analysis of immune cell populations, serum metabolites and hepatocellular carcinoma risk

This multi-omics approach provides evidence for causal relationships between specific immune populations, metabolites, and HCC risk, identifying potential biomarkers and therapeutic targets for HCC prevention and treatment.

Authors

Weiming Shen (ORCID: https://orcid.org/0000-0001-5204-7992)
Yuanying Zeng

Institutions

Suzhou Municipal Hospital (CN)

Publication Details

Journal: Discover Oncology
Published: 2025-07-05
DOI: https://doi.org/10.1007/s12672-025-03037-6
Primary Topic: RNA modifications and cancer
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Mendelian randomization analysis of immune cell populations, serum metabolites and hepatocellular carcinoma risk

Weiming Shen, Yuanying Zeng

Jul 5, 2025

1 links

Discover Oncology

RNA modifications and cancer

article

Mendelian randomization analysis of immune cell populations, serum metabolites and hepatocellular carcinoma risk

Weiming Shen, Yuanying Zeng

July 5, 2025article en

Abstract

Discover OncologyVol. 16(1)

Suzhou Municipal Hospital (CN)

Good health and well-being

Openalex Percentile: Top 85%

RNA modifications and cancer

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Mendelian randomization analysis of immune cell populations, serum metabolites and hepatocellular carcinoma risk — Weiming Shen, Yuanying Zeng · Discover Oncology (2025) | TGRS Research Map | TGRS